Search results for Istiratumab
Istiratumab, Abbexa, abx831341
Istiratumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB3/IGF1R/CD221, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Istiratumab is under investigation in clinical trial NCT02399137 (A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Istiratumab Biosimilar - Research Grade, ichor.bio, ICH5215
Detects IGF1RxHer3
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Istiratumab (HY353076), abinScience, HY353076
Host
Human
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.